Literature DB >> 11584080

Administration of raw onion inhibits platelet-mediated thrombosis in dogs.

W H Briggs1, J D Folts, H E Osman, I L Goldman.   

Abstract

A number of studies suggest that dietary intake of onions is of benefit to cardiovascular health. Onion juice inhibits in vitro human platelet aggregation. To study the in vivo effect of onion on platelet aggregation, 11 dogs were prepared with mechanically damaged and stenosed coronary arteries. Periodic platelet-mediated thrombus formation followed by embolization produced cyclic flow reductions (CFR). In five dogs, 0.09 +/- 0.01 mL/kg onion juice administered intravenously abolished CFR within 20 min. This was followed by a 60 +/- 14% (P = 0.002) reduction in collagen-induced ex vivo whole-blood platelet aggregation. Six dogs were given 2.0 g/kg raw onion homogenate intragastrically. CFR were eliminated within 2.5-3 h in five of the dogs. This was accompanied by a 44 +/- 24% (P = 0.04) reduction in ex vivo aggregation. These findings suggest that the consumption of raw onion may help prevent platelet-mediated cardiovascular disorders. However, in vitro incubations of onion juice demonstrated that the platelet inhibitory response was significantly greater in dog blood than in human blood.

Entities:  

Mesh:

Year:  2001        PMID: 11584080     DOI: 10.1093/jn/131.10.2619

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  13 in total

1.  A structural basis for the inhibition of collagen-stimulated platelet function by quercetin and structurally related flavonoids.

Authors:  Bernice Wright; Leonardo A Moraes; Charles F Kemp; William Mullen; Alan Crozier; Julie A Lovegrove; Jonathan M Gibbins
Journal:  Br J Pharmacol       Date:  2010-02-10       Impact factor: 8.739

2.  Allium vegetable intake and risk of acute myocardial infarction in Italy.

Authors:  Carlotta Galeone; Alessandra Tavani; Claudio Pelucchi; Eva Negri; Carlo La Vecchia
Journal:  Eur J Nutr       Date:  2009-01-13       Impact factor: 5.614

3.  Treatment with quercetin and 3',4'-dihydroxyflavonol inhibits platelet function and reduces thrombus formation in vivo.

Authors:  S Mosawy; D E Jackson; O L Woodman; M D Linden
Journal:  J Thromb Thrombolysis       Date:  2013-07       Impact factor: 2.300

4.  Steam-cooking rapidly destroys and reverses onion-induced antiplatelet activity.

Authors:  Emilie A Hansen; John D Folts; Irwin L Goldman
Journal:  Nutr J       Date:  2012-09-20       Impact factor: 3.271

5.  Some food toxic for pets.

Authors:  Natália Kovalkovičová; Irena Sutiaková; Juraj Pistl; Václav Sutiak
Journal:  Interdiscip Toxicol       Date:  2009-09-28

6.  Synergistic activity of Fagonia arabica and Heteropneustes fossilis extracts against myocardial, cerebral infarction, and embolism disorder in mice.

Authors:  Rakesh Das; Atul Kaushik
Journal:  J Pharm Bioallied Sci       Date:  2010-04

7.  Effects of organic extracts and their different fractions of five Bangladeshi plants on in vitro thrombolysis.

Authors:  Talha Bin Emran; Md Atiar Rahman; Mir Muhammad Nasir Uddin; Md Mominur Rahman; Md Zia Uddin; Raju Dash; Chadny Layzu
Journal:  BMC Complement Altern Med       Date:  2015-04-23       Impact factor: 3.659

8.  Effect of onion and beet on plasma and liver lipids, platelet aggregation, and erythrocyte Na efflux in simvastatin treated hypercholesterolmic rats.

Authors:  Jung Lye Kim; In Sook Chae; Young Hee Kang; Jung Sook Kang
Journal:  Nutr Res Pract       Date:  2008-12-30       Impact factor: 1.926

9.  Effects of organic extracts of six Bangladeshi plants on in vitro thrombolysis and cytotoxicity.

Authors:  M Atiar Rahman; Rabeya Sultana; Talha Bin Emran; M Saiful Islam; M Ashiqur Rahman; Joti Sankhar Chakma; Harun-ur Rashid; Chowdhury Mohammad Monirul Hasan
Journal:  BMC Complement Altern Med       Date:  2013-01-30       Impact factor: 3.659

10.  Effect of Fagonia Arabica (Dhamasa) on in vitro thrombolysis.

Authors:  Sweta Prasad; Rajpal Singh Kashyap; Jayant Y Deopujari; Hemant J Purohit; Girdhar M Taori; Hatim F Daginawala
Journal:  BMC Complement Altern Med       Date:  2007-11-06       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.